Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Link opens in a new tab
Search content at Aston Research Explorer
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?
Asif Ahmed
, Melissa J. Cudmore
College of Health and Life Sciences
School of Biosciences
Aston Medical School
Birmingham Women's NHS Foundation Trust
University College Birmingham
Research output
:
Contribution to journal
›
Article
›
peer-review
61
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Haem Oxygenase
100%
Preeclampsia
100%
Heme oxygenase-1 (HO-1)
100%
Vascular Endothelial Growth Factor Receptor (VEGFR)
50%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
50%
Soluble Endoglin
50%
Endothelial Nitric Oxide Synthase (eNOS)
33%
Health Impact
16%
Phosphorylation
16%
Nitric Oxide
16%
Positive Regulator
16%
New Risks
16%
Cultured Cells
16%
Hypertension
16%
Statins
16%
Protective Effect
16%
Protective Behavior
16%
Nitric Oxide Release
16%
Tissue Explants
16%
Final Common Pathway
16%
Antiangiogenic Factors
16%
Endothelial Damage
16%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
16%
Birth Weight
16%
Proteinuria
16%
Negative Regulator
16%
Pregnant Rats
16%
Vascular Morphogenesis
16%
Vasodilatation
16%
Risk Factors for Cardiovascular Diseases
16%
CO Pathway
16%
CO Carbon Monoxide
16%
Multi-organ
16%
Human Placental Tissue
16%
Clinical Onset
16%
Anti-inflammatory Molecules
16%
Pregnancy Length
16%
Vascular Homeostasis
16%
Prolonged Pregnancy
16%
Length-weight
16%
Pharmacology, Toxicology and Pharmaceutical Science
Oxygenase
100%
Heme
100%
Preeclampsia
100%
Vasculotropin
100%
Protein Tyrosine Kinase
42%
Endoglin
42%
Vasculotropin Receptor 1
42%
Nitric Oxide
28%
Endothelial Nitric Oxide Synthase
28%
Cytokine
14%
Syndrome
14%
Anti-Inflammatory Drug
14%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
14%
Cardiovascular Disease
14%
Antiangiogenic
14%
Carbon Monoxide
14%
Proteinuria
14%
Vasculotropin Receptor 2
14%
Angiogenic Factor
14%
Biochemistry, Genetics and Molecular Biology
Oxygenase
100%
Vascular Endothelial Growth Factor
100%
Eclampsia
100%
Soluble Fms-Like Tyrosine Kinase-1
42%
Endoglin
42%
Nitric Oxide Synthase
28%
Nitric Oxide
28%
Enzyme
14%
Metabolite
14%
Animal Model
14%
Homeostasis
14%
Cytokine
14%
Angiogenesis
14%
Explant
14%
Vasodilatation
14%
VEGF Receptors
14%
Kinase Insert Domain Receptor
14%
Birth Weight
14%
Statin
14%
Anti-Inflammatory
14%